Basilisco, Gerald Wenna .
HRN: 09-36-42 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/05/2026
MUPIROCIN 2%, 15G (TUBE)
01/05/2026
01/05/2026
TOPICAL
1 Squint
2x A Day
Ltcs
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes